Martina Haberecker
Overview
Explore the profile of Martina Haberecker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
3778
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haberecker M, Ruschoff J, Andriakopoulou C, Gray S, Nackaerts K, de Perrot M, et al.
JCO Precis Oncol
. 2025 Feb;
9:e2400675.
PMID: 39938010
Purpose: CD276 (B7-H3) is an immunoregulatory protein that plays an important role in the inhibition of T-cell function. CD276 is overexpressed on a variety of human solid cancer cells with...
2.
Vetter V, Haberecker M, Huber F, Pauli C
Diagn Pathol
. 2024 Sep;
19(1):130.
PMID: 39334415
Backrgound: Merkel cell carcinoma (MCC) is a rare, aggressive primary cutaneous neuroendocrine carcinoma, frequently associated with clonal Merkel cell polyomavirus integration. MCC can pose significant diagnostic challenges due to its...
3.
Roth L, Huynh-Russo L, Heeb L, Ulugol S, Freire Dos Santos R, Breuer E, et al.
Sci Rep
. 2024 Sep;
14(1):22324.
PMID: 39333597
Multimodal therapy for peritoneal metastasis (PM) including cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provides long-term survival in highly selected colorectal cancer patients. Mechanisms behind HIPEC are unknown and...
4.
Reimann R, Gramatzki D, Bink A, Hench J, Frank S, Haberecker M, et al.
J Neuropathol Exp Neurol
. 2024 Sep;
84(2):164-167.
PMID: 39279228
No abstract available.
5.
Chen Y, Steiner S, Hagedorn C, Kollar S, Pliego-Mendieta A, Haberecker M, et al.
J Pathol
. 2024 Apr;
263(2):257-269.
PMID: 38613194
Genomic rearrangements of the neurotrophic receptor tyrosine kinase genes (NTRK1, NTRK2, and NTRK3) are the most common mechanism of oncogenic activation for this family of receptors, resulting in sustained cancer...
6.
Werner R, Curioni-Fontecedro A, Mauti L, Addeo A, Peters S, Frauenfelder T, et al.
J Thorac Oncol
. 2024 Mar;
19(3):385-394.
PMID: 38453327
No abstract available.
7.
Steiner S, Pliego-Mendieta A, Haberecker M, Hussung S, Kollar A, Fritsch R, et al.
Cancer Lett
. 2024 Jan;
584:216650.
PMID: 38246222
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis due to late detection and limited treatment options. Some PDAC patients harbor alterations that qualify for targeted treatment strategies but develop acquired...
8.
Cords L, Engler S, Haberecker M, Ruschoff J, Moch H, de Souza N, et al.
Cancer Cell
. 2024 Jan;
42(3):396-412.e5.
PMID: 38242124
Despite advances in treatment, lung cancer survival rates remain low. A better understanding of the cellular heterogeneity and interplay of cancer-associated fibroblasts (CAFs) within the tumor microenvironment will support the...
9.
Beer P, Pauli C, Haberecker M, Grest P, Beebe E, Fuchs D, et al.
Front Oncol
. 2023 Sep;
13:1210004.
PMID: 37727209
Introduction: Complete surgical tumor resection is paramount in the management of soft tissue sarcoma (STS) in humans, dogs, and cats alike. Near-infrared targeted tracers for fluorescence-guided surgery (FGS) could facilitate...
10.
Ehrsam J, Chen J, Haberecker M, Arni S, Inci I
Transplant Direct
. 2023 Aug;
9(9):e1516.
PMID: 37575952
Methods: Rat single-lung transplantation was performed in 2 groups (n = 8 per group), using Brown-Norway donors and major histocompatibility complex-mismatched Lewis recipients. Recipients of the NAD group received 1000 ...